2016 Q3 Form 10-K Financial Statement
#000114420417059213 Filed on November 15, 2017
Income Statement
| Concept | 2016 Q3 | 2016 | 2015 Q3 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $1.340M | $4.367M | $1.160M |
| YoY Change | 15.52% | 18.02% | 34.88% |
| % of Gross Profit | |||
| Research & Development | $440.0K | $1.683M | $430.0K |
| YoY Change | 2.33% | -4.36% | -18.87% |
| % of Gross Profit | |||
| Depreciation & Amortization | $0.00 | $0.00 | |
| YoY Change | |||
| % of Gross Profit | |||
| Operating Expenses | $1.780M | $6.051M | $1.600M |
| YoY Change | 11.25% | 10.81% | 15.11% |
| Operating Profit | -$6.051M | ||
| YoY Change | 10.81% | ||
| Interest Expense | -$30.00K | $276.7K | $410.0K |
| YoY Change | -107.32% | -26.76% | -79.7% |
| % of Operating Profit | |||
| Other Income/Expense, Net | |||
| YoY Change | |||
| Pretax Income | -$1.820M | -$5.992M | -$1.100M |
| YoY Change | 65.45% | 103.3% | -271.88% |
| Income Tax | |||
| % Of Pretax Income | |||
| Net Earnings | -$1.820M | -$5.992M | -$1.100M |
| YoY Change | 65.45% | 103.3% | -271.88% |
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$12.40K | -$49.33K | -$11.07K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 134.2M shares | 100.6M shares | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2016 Q3 | 2016 | 2015 Q3 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $5.040M | $5.036M | $3.960M |
| YoY Change | 27.27% | 27.18% | 377.11% |
| Cash & Equivalents | $5.036M | $3.960M | |
| Short-Term Investments | |||
| Other Short-Term Assets | $110.0K | $107.8K | $40.00K |
| YoY Change | 175.0% | 151.12% | 0.0% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $5.144M | $5.144M | $4.003M |
| YoY Change | 28.51% | 28.51% | 356.45% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $0.00 | $0.00 | |
| YoY Change | |||
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $0.00 | ||
| YoY Change | |||
| Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| TOTAL ASSETS | |||
| Total Short-Term Assets | $5.144M | $5.144M | $4.003M |
| Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
| Total Assets | $5.144M | $5.144M | $4.003M |
| YoY Change | 28.51% | 28.51% | 356.45% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $374.9K | $374.9K | $231.8K |
| YoY Change | 61.76% | 61.76% | 31.81% |
| Accrued Expenses | $600.0K | $604.3K | $250.0K |
| YoY Change | 140.0% | 146.15% | -7.41% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $900.0K | $899.6K | $470.0K |
| YoY Change | 91.49% | 89.9% | |
| Total Short-Term Liabilities | $1.879M | $1.879M | $1.286M |
| YoY Change | 46.09% | 46.09% | -52.78% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $80.00K | $78.26K | $970.0K |
| YoY Change | -91.75% | -91.91% | 1.04% |
| Other Long-Term Liabilities | $30.00K | $26.23K | $210.0K |
| YoY Change | -85.71% | -87.51% | -94.87% |
| Total Long-Term Liabilities | $104.5K | $104.5K | $1.177M |
| YoY Change | -91.12% | -91.12% | -76.68% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $1.879M | $1.879M | $1.286M |
| Total Long-Term Liabilities | $104.5K | $104.5K | $1.177M |
| Total Liabilities | $1.983M | $1.983M | $2.463M |
| YoY Change | -19.47% | -19.47% | -68.3% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$21.71M | -$15.72M | |
| YoY Change | 38.11% | 23.07% | |
| Common Stock | $24.88M | $17.26M | |
| YoY Change | 44.1% | 193.46% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $3.161M | $3.161M | $1.540M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $5.144M | $5.144M | $4.003M |
| YoY Change | 28.51% | 28.51% | 356.45% |
Cashflow Statement
| Concept | 2016 Q3 | 2016 | 2015 Q3 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$1.820M | -$5.992M | -$1.100M |
| YoY Change | 65.45% | 103.3% | -271.88% |
| Depreciation, Depletion And Amortization | $0.00 | $0.00 | |
| YoY Change | |||
| Cash From Operating Activities | -$1.090M | -$4.747M | -$1.610M |
| YoY Change | -32.3% | 11.97% | 65.98% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $0.00 | ||
| YoY Change | |||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | |||
| YoY Change | |||
| Cash From Investing Activities | $0.00 | ||
| YoY Change | |||
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $100.0K | ||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 370.0K | $5.823M | 2.300M |
| YoY Change | -83.91% | -20.94% | |
| NET CHANGE | |||
| Cash From Operating Activities | -1.090M | -$4.747M | -1.610M |
| Cash From Investing Activities | $0.00 | ||
| Cash From Financing Activities | 370.0K | $5.823M | 2.300M |
| Net Change In Cash | -720.0K | $1.076M | 690.0K |
| YoY Change | -204.35% | -65.57% | -171.13% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$1.090M | -$4.747M | -$1.610M |
| Capital Expenditures | $0.00 | ||
| Free Cash Flow | -$4.747M | ||
| YoY Change |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2016 | arth |
Gain On Exercise Of Warrants
GainOnExerciseOfWarrants
|
142964 | USD |
| CY2017 | arth |
Gain On Exercise Of Warrants
GainOnExerciseOfWarrants
|
0 | USD |
| CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5992370 | USD |
| CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7788856 | USD |
| CY2017 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.05 | |
| CY2016 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.05 | |
| CY2017 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
142722788 | shares |
| CY2016 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
121462897 | shares |
| CY2015Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1540117 | USD |
| CY2016 | arth |
Stock Issued During Period Value Restricted Stock For Services
StockIssuedDuringPeriodValueRestrictedStockForServices
|
52500 | USD |
| CY2017 | arth |
Stock Issued During Period Value Restricted Stock For Services
StockIssuedDuringPeriodValueRestrictedStockForServices
|
162000 | USD |
| CY2016 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
0 | USD |
| CY2017 | arth |
Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
|
0 | USD |
| CY2016 | arth |
Stock Issued During Period Value Private Placement Funding
StockIssuedDuringPeriodValuePrivatePlacementFunding
|
3108939 | USD |
| CY2017 | arth |
Stock Issued During Period Value Private Placement Funding
StockIssuedDuringPeriodValuePrivatePlacementFunding
|
2991012 | USD |
| CY2016 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
644900 | USD |
| CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1098160 | USD |
| CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2105980 | USD |
| CY2016 | arth |
Stock Issued During Period Value Warants Exercised
StockIssuedDuringPeriodValueWarantsExercised
|
2708749 | USD |
| CY2017 | arth |
Stock Issued During Period Value Warants Exercised
StockIssuedDuringPeriodValueWarantsExercised
|
1589888 | USD |
| CY2016 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1098160 | USD |
| CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2105980 | USD |
| CY2016 | arth |
Noncash Interest Expense On Notes Payable
NoncashInterestExpenseOnNotesPayable
|
276687 | USD |
| CY2017 | arth |
Noncash Interest Expense On Notes Payable
NoncashInterestExpenseOnNotesPayable
|
22118 | USD |
| CY2016 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
64865 | USD |
| CY2017 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-22441 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4747027 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
5823403 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
6582510 | USD |
| CY2016 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1076376 | USD |
| CY2017 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
957576 | USD |
| CY2015Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3960100 | USD |
| CY2016Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5036476 | USD |
| CY2017Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5994052 | USD |
| CY2016 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
2708749 | USD |
| CY2017 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
1589888 | USD |
| CY2016 | us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
-192128 | USD |
| CY2017 | us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
433923 | USD |
| CY2017 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | USD |
| CY2016 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
644900 | USD |
| CY2017 | us-gaap |
Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
|
-162000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
|
-52500 | USD |
| CY2017 | arth |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
5987122 | USD |
| CY2016 | arth |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
3114654 | USD |
| CY2017 | arth |
Financing Costs On Issuance Of Common Stock And Warrants
FinancingCostsOnIssuanceOfCommonStockAndWarrants
|
0 | USD |
| CY2016 | arth |
Financing Costs On Issuance Of Common Stock And Warrants
FinancingCostsOnIssuanceOfCommonStockAndWarrants
|
5715 | USD |
| CY2017Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets
|
5323 | USD |
| CY2016Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets
|
3925 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
7129736 | USD |
| CY2016Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
5424530 | USD |
| CY2017Q3 | arth |
Deferred Tax Assets Capitalized Expenditures
DeferredTaxAssetsCapitalizedExpenditures
|
1511187 | USD |
| CY2016Q3 | arth |
Deferred Tax Assets Capitalized Expenditures
DeferredTaxAssetsCapitalizedExpenditures
|
1104928 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
632659 | USD |
| CY2016Q3 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
458417 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
2370477 | USD |
| CY2016Q3 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1463474 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
|
1488 | USD |
| CY2016Q3 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
|
1578 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
20100 | USD |
| CY2016Q3 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
171083 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
11665647 | USD |
| CY2016Q3 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
8624010 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
11665647 | USD |
| CY2016Q3 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
8624010 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2016Q3 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
17960000 | USD |
| CY2016Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
13675000 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
16771000 | USD |
| CY2016Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
12814000 | USD |
| CY2017 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
3041000 | USD |
| CY2016 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
2767000 | USD |
| CY2017 | arth |
License Maintenance Costs
LicenseMaintenanceCosts
|
50000 | USD |
| CY2016Q3 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
977882 | USD |
| CY2013Q2 | arth |
Increase In Aggregate Number Of Shares
IncreaseInAggregateNumberOfShares
|
3000000 | shares |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.7226 | pure |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.1944 | pure |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0114 | pure |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | pure |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0240 | pure |
| CY2017 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
|
0.00 | pure |
| CY2016Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
12379210 | shares |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2700000 | shares |
| CY2017 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
255000 | shares |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
190000 | shares |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
14634210 | shares |
| CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
|
11776130 | shares |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
14634210 | shares |
| CY2016Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.33 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.35 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.65 | |
| CY2017 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Awarded Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAwardedWeightedAverageRemainingContractualTerm
|
P0Y | |
| CY2017 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm
|
P0Y | |
| CY2017 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm
|
P0Y | |
| CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y8M19D | |
| CY2017 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTerm
|
P5Y1M2D | |
| CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P4Y8M19D | |
| CY2017 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Awarded Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAwardedAggregateIntrinsicValue
|
0 | USD |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | USD |
| CY2017 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodAggregateIntrinsicValue
|
0 | USD |
| CY2017 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodAggregateIntrinsicValue
|
5321198 | USD |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
6178263 | USD |
| CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0.39 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.39 | |
| CY2017 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice
|
0.36 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
0.39 | |
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y4M24D | |
| CY2016Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
4341816 | USD |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
6178263 | USD |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
1465861 | shares |
| CY2015Q1 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.20 | |
| CY2014Q4 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
224000 | USD |
| CY2015Q1 | arth |
Gain Loss On Warrant Derivative Modification
GainLossOnWarrantDerivativeModification
|
624016 | USD |
| CY2015Q2 | us-gaap |
Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
|
3263753 | USD |
| CY2017 | dei |
Document Type
DocumentType
|
10-K | |
| CY2017 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2017 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2017-09-30 | |
| CY2017 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2017 | |
| CY2017 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2017 | dei |
Entity Registrant Name
EntityRegistrantName
|
Arch Therapeutics, Inc. | |
| CY2017 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001537561 | |
| CY2017 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--09-30 | |
| CY2017 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2017 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2017 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2017 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2017Q1 | dei |
Entity Public Float
EntityPublicFloat
|
78000000 | USD |
| CY2017 | dei |
Trading Symbol
TradingSymbol
|
ARTH | |
| CY2017Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
153935130 | shares |
| CY2016Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2017Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2017Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2016Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
| CY2016Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
| CY2017Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
153692857 | shares |
| CY2016Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
136657075 | shares |
| CY2016Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
136657075 | shares |
| CY2017Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
153692857 | shares |
| CY2017 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
22100 | USD |
| CY2016 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
8300 | USD |
| CY2017 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> </div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <u><font style="FONT-FAMILY: 'Times New Roman',serif; FONT-SIZE: 10pt">Use of Estimates</font></u></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman',serif; FONT-SIZE: 10pt">  </font></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman',serif; FONT-SIZE: 10pt">Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> </div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <u><font style="FONT-FAMILY: 'Times New Roman',serif; FONT-SIZE: 10pt"> Concentration of Credit Risk</font></u></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman',serif; FONT-SIZE: 10pt">  </font></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman',serif; FONT-SIZE: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash. The Company maintains its cash in bank deposits accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
12611 | USD |
| CY2017 | us-gaap |
Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> </div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <u><font style="FONT-FAMILY: 'Times New Roman',serif; FONT-SIZE: 10pt">Derivative Liabilities</font></u></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman',serif; FONT-SIZE: 10pt">  </font></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman',serif; FONT-SIZE: 10pt">The Company accounts for its warrants and other derivative financial instruments as either equity or liabilities based upon the characteristics and provisions of each instrument, in accordance with FASB ASC Topic 815, Derivatives and Hedging. Warrants classified as equity are recorded at fair value as of the date of issuance on the Company’s consolidated balance sheets and no further adjustments to their valuation are made. Warrants classified as derivative liabilities and other derivative financial instruments that require separate accounting as liabilities are recorded on the Company’s consolidated balance sheets at their fair value on the date of issuance and will be revalued on each subsequent balance sheet date until such instruments are exercised or expire, with any changes in the fair value between reporting periods recorded as other income or expense. Management estimates the fair value of these liabilities using option pricing models and assumptions that are based on the individual characteristics of the warrants or instruments on the valuation date, as well as assumptions for future financings, expected volatility, expected life, yield, and risk-free interest rate.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7188 | USD |
| CY2016Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
0 | USD |
| CY2016Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3925 | USD |
| CY2017Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3500 | USD |
| CY2016Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
0 | USD |
| CY2017Q3 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
10688 | USD |
| CY2016Q3 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
0 | USD |
| CY2017Q3 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
3430033 | USD |
| CY2016Q3 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
0 | USD |
| CY2016 | arth |
Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
|
0 | USD |
| CY2017 | us-gaap |
Depreciation
Depreciation
|
1498 | USD |
| CY2016 | us-gaap |
Depreciation
Depreciation
|
0 | USD |
| CY2017 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-331000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
0 | USD |
| CY2017Q3 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
0 | USD |
| CY2016Q3 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
0 | USD |
| CY2017 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
8686 | USD |
| CY2016 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-8686 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | USD |
| CY2017 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
5500 | USD |
| CY2016 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | USD |
| CY2017 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
1000000 | USD |
| CY2016 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | USD |
| CY2017 | us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
2996110 | USD |
| CY2016 | us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
0 | USD |
| CY2017 | us-gaap |
Stock Issued1
StockIssued1
|
106 | USD |
| CY2016 | us-gaap |
Stock Issued1
StockIssued1
|
69 | USD |
| CY2017 | arth |
Warrant Exercised In Cashless Basis
WarrantExercisedInCashlessBasis
|
19 | USD |
| CY2016 | arth |
Warrant Exercised In Cashless Basis
WarrantExercisedInCashlessBasis
|
2334 | USD |
| CY2017 | us-gaap |
Interest Paid Net
InterestPaidNet
|
361268 | USD |
| CY2016 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD |
| CY2017 | arth |
Stock Issued During Period Value Cashless Stock Options Exercised One
StockIssuedDuringPeriodValueCashlessStockOptionsExercisedOne
|
5500 | USD |
| CY2017 | arth |
Stock Issued During Period Value Cashless Stock Options Exercised Two
StockIssuedDuringPeriodValueCashlessStockOptionsExercisedTwo
|
0 | USD |
| CY2017 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
3500 | USD |
| CY2016 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
0 | USD |
| CY2017Q3 | us-gaap |
Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
|
354988 | USD |
| CY2017 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
395012 | USD |
| CY2017 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
131252 | USD |
| CY2016Q3 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
0 | USD |
| CY2017Q3 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
0 | USD |
| CY2016 | arth |
License Maintenance Costs
LicenseMaintenanceCosts
|
50000 | USD |
